Contact

Email

mwood@unimelb.edu.au

Credentials

Position
Clinical (Associate Professor)
Department of Medicine

A/Prof Michael Woodward

Clinical (Associate Professor)
Department of Medicine
177 Scholarly works
2 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Charting the research frontier for viral infections, immunomodulation, and dementia: a perspective on synaptic biomarkers as essential clinical trial endpoints
    DOI: 10.3389/fcimb.2025.1701760
  • 2025

    Journal article

    Public Health
    DOI: 10.1002/alz70860_102814
  • 2025

    Journal article

    Biomarkers
    DOI: 10.1002/alz70856_099163
  • 2025

    Journal article

    Monoclonal Antibody Therapies in Alzheimer's Disease: A Guide for Emergency Physicians
    DOI: 10.1111/1742-6723.70167
  • 2021

    Research Grant

    Remote Expert Nurse Consultation for Pressure Injury Prevention and Management in Residential Aged Care
  • 2021

    Research grants (other domestic)

    Remote Expert Nurse Consultation for Pressure Injury Prevention and Management in Residential Aged Care
  • 2013

    Journal article

    Prediction of amyloid-β pathology in amnestic mild cognitive impairment with neuropsychological tests
    DOI: 10.3233/JAD-2012-121315
Michael Woodward

RECENT SCHOLARLY WORKS

  • 2025

    Journal article

    Is Australia ready for the rollout of amyloid-targeting therapies for Alzheimer disease? Results from a national survey characterising current infrastructure capability, workforce and training needs of memory and cognition clinics
    DOI: 10.1111/imj.16637
  • 2025

    Journal article

    Integrating lived experience to develop a tailored sleep intervention for people living with dementia and carepartners
    DOI: 10.1177/14713012241282769
  • 2025

    Journal article

    Clinical Pharmacology and Approach to Dose Selection of Emestedastat, a Novel Tissue Cortisol Synthesis Inhibitor for the Treatment of Central Nervous System Disease
    DOI: 10.1002/cpdd.1496
  • 2025

    Journal article

    Deferiprone in Alzheimer Disease: A Randomized Clinical Trial
    DOI: 10.1001/jamaneurol.2024.3733
  • 2025

    Journal article

    Mild cognitive impairment and dementia The treatment landscape
  • 2025

    Journal article

    Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial
    DOI: 10.1016/j.tjpad.2024.100016